ROYALTY AND LICENSE FEE SHARING AGREEMENTRoyalty and License Fee Sharing Agreement • December 3rd, 2019 • Qrons Inc. • Biological products, (no disgnostic substances) • New York
This Royalty and License Fee Sharing Agreement (the “Agreement”) is entered into as of November 30, 2019 (the “Effective Date”), between Qrons Inc., a Wyoming corporation (the “Company”) and Ariel Scientific Innovations Ltd. (formerly known as Ariel R&D Co., Ltd.), a company organized under the laws of Israel ("Ariel", and together with the Company, the “Parties” and each a “Party” ).
October 28, 2024 VIA EMAIL DELIVERY: Mr. Adiv Baruch, Chairman Mr. Danny Hardon, CEO Ariel Scientific Innovations Ltd. Ariel University Ariel 40070 Israel Re: Royalty and License Fee Sharing Agreement dated as of November 30, 2019 ( the “Agreement”)...Royalty and License Fee Sharing Agreement • November 8th, 2024 • Qrons Inc. • Biological products, (no disgnostic substances)
An Exit Event as defined by the above caption Agreement has occurred whereby Qrons has agreed to enter into a merger agreement. Pursuant to Paragraph 2, Qrons is issuing to Ariel University 3% of its issued and outstanding shares. Qrons currently has 13,949,789 such shares and will issue to Ariel 418,494 shares to be deposited into Ariel’s account at the Company’s Transfer Agent.
